Rybrevant 350 mg/1
amivantamab-vmjw · INJECTION · Janssen Biotech, Inc.
No Recall History
Plain English
Rybrevant is a injection containing amivantamab-vmjw at 350 mg/1, taken intravenous. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- Rybrevant
- Generic Name
- amivantamab-vmjw
- NDC Code (Product)
57894-501- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 350 mg/1
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761210
- Marketing Start
- 05/21/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Rybrevant used for?
Rybrevant contains amivantamab-vmjw. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Rybrevant a controlled substance?
Rybrevant is not classified as a controlled substance by the DEA.
What is the generic name for Rybrevant?
The generic name for Rybrevant is amivantamab-vmjw. There are no other listed brand versions of amivantamab-vmjw.
What is the NDC code for Rybrevant 350 mg/1?
The NDC (National Drug Code) for Rybrevant 350 mg/1 is 57894-501, listed by Janssen Biotech, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)